- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Pharmala Biotech Holdings Inc: Pharmala begins second MDMA batch with Cortexa JV | 1 | Stockwatch | ||
| Mo | PharmAla Biotech: Cortexa Advances Commercialisation of MDMA Supply in Australia | 100 | GlobeNewswire (Europe) | MELBOURNE, Australia, March 23, 2026 (GLOBE NEWSWIRE) -- Cortexa (Cortexa or the Company), a leading psychedelic medicines supplier, reaffirms its market leading position in FY2026 for MDMA (3,4-methylenedioxymethamphetamine).... ► Artikel lesen | |
| 03.03. | Pharmala Biotech Holdings Inc: Pharmala Biotech to supply MDMA for U.S. study | 4 | Stockwatch | ||
| PHARMALA BIOTECH Aktie jetzt für 0€ handeln | |||||
| 03.03. | PharmAla signs MDMA supply deal with Nautilus Sanctuary | 1 | Investing.com | ||
| 27.02. | Pharmala Biotech Holdings Inc: Pharmala signs drug donation deal with Spaulding | 3 | Stockwatch | ||
| 26.02. | PharmAla Biotech: PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia | 1 | GlobeNewswire (USA) | ||
| 24.02. | Pharmala Biotech Holdings Inc: Pharmala signs supply deal with Amsterdam UMC | 2 | Stockwatch | ||
| 23.02. | PharmAla Biotech: PharmAla To Supply Amsterdam UMC with LaNeo MDMA, Including Development of New Single-Capsule Stability Data | 252 | GlobeNewswire (Europe) | TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo MDMA and... ► Artikel lesen | |
| 11.02. | Pharmala Biotech Holdings Inc: Pharmala Biotech appoints Ryer as director | 2 | Stockwatch | ||
| 10.02. | PharmAla Biotech announces board changes, appoints new director | 1 | Investing.com | ||
| 10.02. | PharmAla Biotech: PharmAla Announces Changes to Board of Directors | 1 | GlobeNewswire (USA) | ||
| 09.01. | Pharmala Biotech Holdings Inc: Pharmala to supply LaNeo for Ostfold clinical research | 2 | Stockwatch | ||
| 08.01. | PharmAla Biotech: PharmAla To Supply Østfold Hospital Trust with LaNeo MDMA for Clinical Research | 1 | GlobeNewswire (USA) | ||
| 24.12.25 | Pharmala Biotech Holdings Inc: Pharmala Biotech files fiscal 2025, Q1 2026 financials | 4 | Stockwatch | ||
| 24.12.25 | PharmAla Biotech: PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements | 276 | GlobeNewswire (Europe) | TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and... ► Artikel lesen | |
| 16.12.25 | Pharmala Biotech Holdings Inc: Pharmala Biotech Australia hires CDMO for manufacturing | 1 | Stockwatch | ||
| 11.12.25 | Pharmala Biotech Holdings Inc: Pharmala completes release testing on LaNeo capsules | 1 | Stockwatch | ||
| 10.12.25 | PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules | 1 | GlobeNewswire (USA) | ||
| 04.11.25 | Pharmala Biotech Holdings Inc: Pharmala Biotech files final prospectus | 1 | Stockwatch | ||
| 03.11.25 | PharmAla Biotech: PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital | 243 | GlobeNewswire (Europe) | TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and... ► Artikel lesen |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DAY ONE BIOPHARMACEUTICALS | 21,380 | +0,09 % | Weekly Buzz: Bristol Myers Squibb Wins FDA Nod; EU Okays Johnson & Johnson's AKEEGA; Ipsen Withdraws Tazverik, Day One Biopharmaceuticals Acquired | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed key FDA approvals, EU approvals, IND clearances, acquisitions, and clinical trial data readouts across key therapeutic areas... ► Artikel lesen | |
| ADMA BIOLOGICS | 11,330 | -16,51 % | ADMA Biologics drops amid short report from Culper Research | ||
| QIAGEN | 34,465 | 0,00 % | QIAGEN N.V.: Qiagen Announces Form 20-F Annual Report Filing for 2025 Results | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended... ► Artikel lesen | |
| EDGEWISE THERAPEUTICS | 30,640 | +2,82 % | Why Edgewise Therapeutics Stock Topped the Market on Tuesday | ||
| KINIKSA PHARMACEUTICALS | 44,940 | -2,33 % | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution | - ARCALYST- (rilonacept) Q4 2025 and full year 2025 net product revenue of $202.1 million and $677.6 million, respectively -- ARCALYST 2026 net product revenue expected to be $900 - $920 million... ► Artikel lesen | |
| VIR BIOTECHNOLOGY | 8,570 | -3,05 % | Vir Biotechnology +70%: Deal-Überraschung mit Ansage | Die Aktie von Vir Biotechnology ist vorbörslich um rund 70 Prozent nach oben geschossen. Auslöser der Kursexplosion ist vor allem ein milliardenschwerer Kooperationsdeal mit dem japanischen Pharmakonzern... ► Artikel lesen | |
| ARCELLX | 114,66 | +0,05 % | Arcellx legt Zahlen vor - Augenmerk liegt auf Gilead-Übernahme | ||
| APOGEE THERAPEUTICS | 72,98 | -7,81 % | Morning Market Movers: urban-gro, WeShop Holdings, QVC Group, Apogee Therapeutics See Big Swings | OTTAWA (dpa-AFX) - At 8:30 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PHATHOM PHARMACEUTICALS | 10,060 | 0,00 % | Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results | FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal... ► Artikel lesen | |
| CONTINEUM THERAPEUTICS | 12,330 | -0,56 % | Stifel reiterates Buy on Contineum stock, keeps $29 price target | ||
| EVOTEC | 4,119 | 0,00 % | EQS-News: Evotec SE: Evotec erhält 10 Mio. $ Meilensteinzahlung von Bristol Myers Squibb im Rahmen der Protein-Degradation-Partnerschaft nach Start einer klinischen Studie | EQS-News: Evotec SE
/ Schlagwort(e): Sonstiges
Evotec erhält 10 Mio. $ Meilensteinzahlung von Bristol Myers Squibb im Rahmen der Protein-Degradation-Partnerschaft nach Start einer... ► Artikel lesen | |
| TANGO THERAPEUTICS | 19,480 | +2,74 % | Erasca, Inc.: Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat | ERAS-0015, a pan-RAS molecular glue, will be evaluated in combination with PRMT5 inhibitor vopimetostat Tango will sponsor the clinical trial and Erasca will supply ERAS-0015 at no cost SAN DIEGO... ► Artikel lesen | |
| ERASCA | 14,645 | 0,00 % | Erasca (ERAS) Adds 13%; Soars 310% YTD | ||
| LENZ THERAPEUTICS | 9,010 | -18,09 % | LENZ Therapeutics, Inc.: LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights | Launched VIZZ- (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in October 2025 and generated net product revenues of $1.6 million in the first quarter of launch On pace for... ► Artikel lesen | |
| LEXEO THERAPEUTICS | 5,500 | -0,36 % | Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy | LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, and increased protein expression observed across participants... ► Artikel lesen |
Das Unternehmen PHARMALA BIOTECH HOLDINGS INC kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMALA BIOTECH HOLDINGS INC finden Sie auf Wallstreet Online.